173 related articles for article (PubMed ID: 36117731)
1. CSTF2 Acts as a Prognostic Marker Correlated with Immune Infiltration in Hepatocellular Carcinoma.
Zhang W; Wan Y; Zhang Y; Liu Q; Zhu X
Cancer Manag Res; 2022; 14():2691-2709. PubMed ID: 36117731
[TBL] [Abstract][Full Text] [Related]
2. A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma.
Huang Y; Xu J; Xie C; Liao Y; Lin R; Zeng Y; Yu F
J Hepatocell Carcinoma; 2023; 10():1639-1657. PubMed ID: 37791068
[TBL] [Abstract][Full Text] [Related]
3. CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression
Chen Z; Hao W; Tang J; Gao WQ; Xu H
Front Oncol; 2022; 12():897804. PubMed ID: 35875122
[TBL] [Abstract][Full Text] [Related]
4. Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway.
Zhang MH; Liu J
Bioengineered; 2022 Apr; 13(4):10047-10060. PubMed ID: 35412944
[TBL] [Abstract][Full Text] [Related]
5. NAP1L1 Functions as a Novel Prognostic Biomarker Associated With Macrophages and Promotes Tumor Progression by Influencing the Wnt/β-Catenin Pathway in Hepatocellular Carcinoma.
Shen B; Zhu W; Liu X; Jiang J
Front Genet; 2022; 13():876253. PubMed ID: 35664324
[TBL] [Abstract][Full Text] [Related]
6. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
7. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
Fu XW; Song CQ
Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
[No Abstract] [Full Text] [Related]
9. High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma.
Ren Y; Qian Y; Zhang Q; Li X; Li M; Li W; Yang P; Ren H; Li H; Weng Y; Li D; Xu K; Yu W
Cancer Cell Int; 2024 Apr; 24(1):142. PubMed ID: 38643145
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis.
Liu L; Wang Q; Wu L; Zhang L; Huang Y; Yang H; Guo L; Fang Z; Wang X
Cancer Cell Int; 2023 Jul; 23(1):138. PubMed ID: 37452331
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma.
Zhu XR; Zhu JQ; Chen YF; Liu YY; Lu JJ; Sun J; Peng SQ; Chen MB; Du YP
Front Oncol; 2022; 12():972744. PubMed ID: 35982956
[TBL] [Abstract][Full Text] [Related]
13. ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway.
Ding Y; Ning Y; Kang H; Yuan Y; Lin K; Wang C; Yi Y; He J; Li L; He X; Chang Y
Exp Hematol Oncol; 2024 Jan; 13(1):5. PubMed ID: 38254216
[TBL] [Abstract][Full Text] [Related]
14. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
Front Surg; 2022; 9():836080. PubMed ID: 35392063
[TBL] [Abstract][Full Text] [Related]
15. Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma.
Fan Y; Hou J; Liu X; Han B; Meng Y; Liu B; Chen F; Shang Y; Cao P; Tan K
Front Genet; 2021; 12():668516. PubMed ID: 34917120
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.
Aragaki M; Takahashi K; Akiyama H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Sep; 17(18):5889-900. PubMed ID: 21813631
[TBL] [Abstract][Full Text] [Related]
17. The Biological Function of POLA2 in Hepatocellular Carcinoma.
Yang Z; Shen X; Wang Z; Li R; Hou W; Liu Z; Gao Y; Zhu C; Qin X
Comb Chem High Throughput Screen; 2023 Oct; ():. PubMed ID: 37861044
[TBL] [Abstract][Full Text] [Related]
18. CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
He K; Xie M; Li J; He Y; Yin Y
Int J Gen Med; 2022; 15():7493-7510. PubMed ID: 36187159
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
20. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
